Leerink Partners Likes WebMD Health (WBMD), Reiterates OP

Leerink Partners reiterates an Outperform rating on WebMD Health Corp. (NASDAQ: WBMD) with a price target set at $54. WebMD reported revenue of $143.3m and YoY growth of 7%. Management reaffirmed guidance for 2015, projecting a growth rate of 8%.

Leerink analyst Steven Wardel commented, "EPS for the quarter came in at $0.25, beating FactSet consensus by $0.03 or 14%. The beat was primarily attributable to lower YoY Sales & Marketing margin and lower G&A margin. Management affirmed guidance for the year with the company on track to grow Net Income 34% in 2015."

Wardel added that, "We believe that WebMD is well positioned to capitalize on the growth and major changes that are affecting the healthcare industry and that are making WebMD’s core assets – the leading online audience of healthcare consumers and physicians in the US health information marketspace – increasingly valuable."

For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.

Shares of WebMD Health Corp. closed at $42.20 yesterday.

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy
• McGraw Hill (MH) PT Raised to $15 at UBS